Get the Stockscreener App
1.08
0.92%
-0.01
Ainos Inc stock is currently priced at $1.08, with a 24-hour trading volume of 28,507.
It has seen a -0.92% decreased in the last 24 hours and a -7.69% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.09 pivot point. If it approaches the $1.04 support level, significant changes may occur.
Previous Close:
$1.09
Open:
$1.1
24h Volume:
28,507
Market Cap:
$6.57M
Revenue:
$122.10K
Net Income/Loss:
$-13.77M
P/E Ratio:
-1.4211
EPS:
-0.76
Net Cash Flow:
$-4.79M
1W Performance:
+3.85%
1M Performance:
-7.69%
6M Performance:
+68.80%
1Y Performance:
+35.00%
1D Range:
$1.06
$1.11
52W Range:
$0.5019
$4.2899
Ainos Inc Stock (AIMD) Company Profile
Name
Ainos Inc
Sector
Industry
Phone
858 869 2986
Address
8880 Rio San Diego Drive, Suite 800, San Diego
Ainos Inc Stock (AIMD) Latest News
What Data Should You Use to Trade Penny Stocks?
PennyStocks
How Elections Impact Penny Stocks
PennyStocks
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Nasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In February
Benzinga
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Ainos Inc Stock (AIMD) Financials Data
Ainos Inc (AIMD) Revenue 2024
AIMD reported a revenue (TTM) of $122.10 thousand for the quarter ending December 31, 2023, a -96.53% decline year-over-year.
Ainos Inc (AIMD) Net Income 2024
AIMD net income (TTM) was -$13.77 million for the quarter ending December 31, 2023, a +1.69% increase year-over-year.
Ainos Inc (AIMD) Cash Flow 2024
AIMD recorded a free cash flow (TTM) of -$4.79 million for the quarter ending December 31, 2023, a -30.29% decrease year-over-year.
Ainos Inc (AIMD) Earnings per Share 2024
AIMD earnings per share (TTM) was -$3.41 for the quarter ending December 31, 2023, a +26.51% growth year-over-year.
About Ainos Inc
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
5.81%
Cap:
|
Volume (24h):